Life Technologies Corporation recalls Human Fetal Hemoglobin (HBF-1) FITC Conjugate

Recall date

February 7, 2018

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

Z-1388-2018

FDA classification

Class II

Brand / firm

Life Technologies Corporation

Sold / distributed

MI, CA, IL, TX, SC, NY, MN, DE, NJ, WA , OR, IN, MA, DE, FL, PA

Why it was recalled

Three lots of Human Fetal Hemoglobin FITC Conjugate are displaying high background and unusual bright staining in the controls and patient samples which could potentially lead to erroneous results (i.e. false positives)

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Human Fetal Hemoglobin (HBF-1) FITC Conjugate